Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications
- 14 December 2006
- journal article
- Published by Wiley in Liver International
- Vol. 27 (4) , 475-484
Abstract
Background: Numerous, mostly uncontrolled, observations suggest that artificial liver support with the Molecular Adsorbent Recirculating System (MARS) improves pathophysiologic sequelae and outcome of acute and acute‐on‐chronic liver failure. MARS is felt to be safe, but extracorporeal circuits may activate coagulation.Objective: To assess the frequency of and risk factors for activation of coagulation during MARS treatment.Patients/Methods: Retrospective analysis of coagulopathy/bleeding complications observed during 83 consecutive MARS sessions in 21 patients (11 men; median age 46 years; median three sessions per patient; median duration of session 8 h).Results: Nine clinically relevant episodes of coagulopathy/bleeding were observed in eight patients, forced to premature cessation of MARS in seven and ended lethal in four. Four complications occurred during the first, five during later (third to seventh) MARS sessions and two bleeders tolerated further sessions without complications. Coagulation parameters worsened significantly also during MARS sessions not associated with bleeding (P≤0.004). In univariate analysis, patient's age, vasopressor therapy, pretreatment INR, fibrin D–dimer and fibrinogen concentrations, but not severity of underlying disease (MELD, Child‐Pugh, SAPS II scores), were significantly associated with coagulopathy (PConclusion: Coagulation is frequently activated during MARS therapy, potentially leading to bleeding complications and mortality.Keywords
This publication has 37 references indexed in Scilit:
- Patients with acute on chronic liver failure display ‘sepsis-like’ immune paralysisJournal of Hepatology, 2005
- Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating systemClinical Transplantation, 2004
- Successful use of the Molecular Adsorbent Recirculating System (MARS) in a patient with primary biliary cirrhosis (PBC) and treatment refractory pruritusHepatology Research, 2003
- Characterization of treatment dose delivered by albumin dialysis in the treatment of acute renal failure associated with severe hepatic dysfunctionClinical Nephrology, 2002
- Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled studyHepatology, 2002
- First clinical experience with Molecular Adsorbent Recirculating System (MARS) in six patients with severe acute on chronic liver failureLiver International, 2002
- Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failureLiver Transplantation, 2001
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001
- Molecular Adsorbent Recycling System (MARS): Clinical Results of a New Membrane‐Based Blood Purification System for Bioartificial Liver SupportArtificial Organs, 1999
- Platelet function in fulminant hepatic failure and effect of charcoal haemoperfusion.Gut, 1977